BiotechTube
Avenna

Avenna

Cambridge, United Kingdom· Est.
avenna.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Avenna, spun out from Ludger in 2017, is a private, pre-revenue diagnostics company leveraging glycomics to develop blood-based biomarkers for chronic inflammatory diseases. Its core platform, GlyHealth, aims to measure and track chronic inflammation without acute inflammation interference, facilitating early detection and treatment personalization. The company targets individuals, clinicians, and biopharma partners with the goal of reducing healthcare costs and improving patient outcomes in a vast market driven by non-communicable diseases.

Inflammatory Bowel Disease (IBD)Rheumatoid Arthritis (RA)Chronic Inflammatory Diseases

Technology Platform

Glycomic biomarker platform (GlyHealth) for blood-based profiling of chronic inflammation, specifically designed to avoid acute inflammation interference.

Opportunities

The massive and growing global burden of chronic inflammatory diseases creates a urgent need for better diagnostic tools.
The shift towards precision medicine and value-based healthcare provides a strong tailwind for biomarkers that can enable early intervention, personalized therapy, and more efficient drug development.

Risk Factors

Key risks include the failure to clinically validate the glycomic biomarkers for regulatory approval, challenges in commercial adoption and reimbursement in a crowded diagnostics market, and reliance on securing sufficient funding as a pre-revenue, early-stage company.

Competitive Landscape

Avenna competes with established inflammation marker tests (e.g., CRP, ESR) and a growing field of companies developing multi-omic and digital biomarkers for chronic diseases. Its differentiation hinges on the specific glycomic signature for chronic inflammation, but it must prove clinical utility and cost-effectiveness to gain market share.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →